Hangzhou Phecdamed Co., Ltd.
Clinical trials sponsored by Hangzhou Phecdamed Co., Ltd., explained in plain language.
-
First human tests: scientists check safety of new pill
Knowledge-focused CompletedThis was an early-stage study to check the safety and see how the body processes a new experimental capsule called TJ0113. It involved 130 healthy adult volunteers who took single or multiple doses of the capsule or a placebo. The main goal was to see if the capsule was safe and …
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists trace new Drug's journey through the body
Knowledge-focused CompletedThis study aimed to understand how a new drug called TJ0113 is processed by the body. Six healthy adult men took a single dose containing a tiny, safe amount of radioactive tracer. Researchers then carefully measured how much of the drug and its byproducts appeared in their blood…
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC